{"parse":{"title":"Antidepressant discontinuation syndrome","pageid":2780034,"revid":859285581,"text":{"*":"<div class=\"mw-parser-output\"><div role=\"note\" class=\"hatnote navigation-not-searchable\">Not to be confused with <a href=\"/wiki/Serotonin_syndrome\" title=\"Serotonin syndrome\">Serotonin syndrome</a>.</div>\n<table class=\"infobox\" style=\"width:22em\"><tbody><tr><th colspan=\"2\" style=\"text-align:center;font-size:125%;font-weight:bold;background:#ccc\">Antidepressant discontinuation syndrome</th></tr><tr><th scope=\"row\">Synonyms</th><td>\nAntidepressant withdrawal syndrome<sup id=\"cite_ref-TI2018_1-0\" class=\"reference\"><a href=\"#cite_note-TI2018-1\">&#91;1&#93;</a></sup></td></tr><tr><th scope=\"row\"><a href=\"/wiki/Specialty_(medicine)\" title=\"Specialty (medicine)\">Specialty</a></th><td>\n<a href=\"/wiki/Psychiatry\" title=\"Psychiatry\">Psychiatry</a></td></tr><tr><th scope=\"row\">Symptoms</th><td>\n<a href=\"/wiki/Flu-like_symptoms\" class=\"mw-redirect\" title=\"Flu-like symptoms\">Flu-like symptoms</a>, trouble sleeping, nausea, poor balance, sensory changes<sup id=\"cite_ref-War2006_2-0\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup></td></tr><tr><th scope=\"row\">Usual onset</th><td>\nWithin 3 days<sup id=\"cite_ref-War2006_2-1\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup></td></tr><tr><th scope=\"row\">Duration</th><td>\n1-2 weeks<sup id=\"cite_ref-War2006_2-2\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup></td></tr><tr><th scope=\"row\">Causes</th><td>\nSudden stopping of an <a href=\"/wiki/Antidepressant_medication\" class=\"mw-redirect\" title=\"Antidepressant medication\">antidepressant medication</a><sup id=\"cite_ref-War2006_2-3\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup></td></tr><tr><th scope=\"row\"><a href=\"/wiki/Diagnostic_method\" class=\"mw-redirect\" title=\"Diagnostic method\">Diagnostic method</a></th><td>\nBased on symptoms<sup id=\"cite_ref-War2006_2-4\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup></td></tr><tr><th scope=\"row\"><a href=\"/wiki/Differential_diagnosis\" title=\"Differential diagnosis\">Differential diagnosis</a></th><td>\n<a href=\"/wiki/Anxiety\" title=\"Anxiety\">Anxiety</a>, <a href=\"/wiki/Mania\" title=\"Mania\">mania</a>, <a href=\"/wiki/Stroke\" title=\"Stroke\">stroke</a><sup id=\"cite_ref-War2006_2-5\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup></td></tr><tr><th scope=\"row\">Prevention</th><td>\nGradual dose reduction<sup id=\"cite_ref-War2006_2-6\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup></td></tr><tr><th scope=\"row\">Frequency</th><td>\nc. 20% (with sudden stopping)<sup id=\"cite_ref-War2006_2-7\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup></td></tr></tbody></table>\n<p><b>Antidepressant discontinuation syndrome</b>, also called <b>antidepressant withdrawal syndrome</b>, is a condition that can occur following the interruption, reduction, or <a href=\"/wiki/Medication_discontinuation\" title=\"Medication discontinuation\">discontinuation</a> of <a href=\"/wiki/Antidepressant_medication\" class=\"mw-redirect\" title=\"Antidepressant medication\">antidepressant medication</a>.<sup id=\"cite_ref-War2006_2-8\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup> The symptoms may include <a href=\"/wiki/Flu-like_symptoms\" class=\"mw-redirect\" title=\"Flu-like symptoms\">flu-like symptoms</a>, trouble sleeping, nausea, poor balance, sensory changes, and <a href=\"/wiki/Anxiety\" title=\"Anxiety\">anxiety</a>.<sup id=\"cite_ref-War2006_2-9\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Gab2017_3-0\" class=\"reference\"><a href=\"#cite_note-Gab2017-3\">&#91;3&#93;</a></sup> The problem usually begins within three days and lasts up to two weeks.<sup id=\"cite_ref-War2006_2-10\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup> Rarely <a href=\"/wiki/Psychosis\" title=\"Psychosis\">psychosis</a> may occur.<sup id=\"cite_ref-War2006_2-11\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup>\n</p><p>A discontinuation syndrome can occur after stopping any antidepressant including <a href=\"/wiki/Selective_serotonin_reuptake_inhibitor\" title=\"Selective serotonin reuptake inhibitor\">selective serotonin re-uptake inhibitors</a> (SSRIs), <a href=\"/wiki/Serotonin%E2%80%93norepinephrine_reuptake_inhibitor\" title=\"Serotonin\u2013norepinephrine reuptake inhibitor\">serotonin\u2013norepinephrine reuptake inhibitors</a> (SNRIs), and <a href=\"/wiki/Tricyclic_antidepressants\" class=\"mw-redirect\" title=\"Tricyclic antidepressants\">tricyclic antidepressants</a> (TCAs).<sup id=\"cite_ref-War2006_2-12\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Gab2017_3-1\" class=\"reference\"><a href=\"#cite_note-Gab2017-3\">&#91;3&#93;</a></sup> The risk is greater among those who have taken the medication for longer and when the medication in question has a short <a href=\"/wiki/Half-life\" title=\"Half-life\">half-life</a>.<sup id=\"cite_ref-War2006_2-13\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup> The underlying reason for its occurrence is unclear.<sup id=\"cite_ref-War2006_2-14\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup> The diagnosis is based on the symptoms.<sup id=\"cite_ref-War2006_2-15\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup>\n</p><p>Methods of prevention include gradually decreasing the dose among those who wish to stop, though symptoms can still occur with tapering.<sup id=\"cite_ref-War2006_2-16\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Wil2015_4-0\" class=\"reference\"><a href=\"#cite_note-Wil2015-4\">&#91;4&#93;</a></sup> Treatment may include restarting the medication and slowly decreasing the dose.<sup id=\"cite_ref-War2006_2-17\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup> People may also be switched to the long acting antidepressant <a href=\"/wiki/Fluoxetine\" title=\"Fluoxetine\">fluoxetine</a> which can then be gradually decreased.<sup id=\"cite_ref-Wil2015_4-1\" class=\"reference\"><a href=\"#cite_note-Wil2015-4\">&#91;4&#93;</a></sup> The condition is generally not serious.<sup id=\"cite_ref-War2006_2-18\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup> Approximately 20% of people who suddenly stop an antidepressant develop these problems.<sup id=\"cite_ref-War2006_2-19\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Gab2017_3-2\" class=\"reference\"><a href=\"#cite_note-Gab2017-3\">&#91;3&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Signs_and_symptoms\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Signs and symptoms</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Duration\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Duration</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Mechanism\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Mechanism</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Prevention_and_treatment\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Prevention and treatment</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Pregnancy_and_newborns\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">Pregnancy and newborns</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Culture_and_history\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Culture and history</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#2013_class_action_lawsuit\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">2013 class action lawsuit</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#Research\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Research</span></a></li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#See_also\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#References\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#External_links\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Signs_and_symptoms\">Signs and symptoms</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antidepressant_discontinuation_syndrome&amp;action=edit&amp;section=1\" title=\"Edit section: Signs and symptoms\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>People with antidepressant discontinuation syndrome have been on an <a href=\"/wiki/Antidepressant\" title=\"Antidepressant\">antidepressant</a> for at least four weeks and have recently stopped taking the medication, whether abruptly, after a fast taper, or each time the medication is reduced on a slow taper.<sup id=\"cite_ref-War2006_2-20\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup> Commonly reported symptoms include flu-like symptoms (nausea, vomiting, diarrhea, headaches, sweating) and sleep disturbances (insomnia, nightmares, constant sleepiness). Sensory and movement disturbances have also been reported, including <a href=\"/wiki/Balance_(ability)\" title=\"Balance (ability)\">imbalance</a>, <a href=\"/wiki/Tremor\" title=\"Tremor\">tremors</a>, <a href=\"/wiki/Vertigo\" title=\"Vertigo\">vertigo</a>, dizziness, and electric-shock-like experiences in the brain, often described by people who have them as \"brain zaps\". Mood disturbances such as <a href=\"/wiki/Dysphoria\" title=\"Dysphoria\">dysphoria</a>, anxiety, or agitation are also reported, as are cognitive disturbances such as confusion and <a href=\"/wiki/Fight-or-flight_response\" title=\"Fight-or-flight response\">hyperarousal</a>.\n</p><p>In cases associated with sudden discontinuation of <a href=\"/wiki/Monoamine_oxidase_inhibitor\" title=\"Monoamine oxidase inhibitor\">MAO inhibitors</a>, acute <a href=\"/wiki/Psychosis\" title=\"Psychosis\">psychosis</a> has been observed.<sup id=\"cite_ref-War2006_2-21\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Haddad2007_5-0\" class=\"reference\"><a href=\"#cite_note-Haddad2007-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-Renoir2013_6-0\" class=\"reference\"><a href=\"#cite_note-Renoir2013-6\">&#91;6&#93;</a></sup>  Over fifty symptoms have been reported.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\n</p><p>Most cases of discontinuation syndrome may last between one and four weeks, are relatively mild, and resolve on their own; in more severe cases, symptoms can be severe or extended.<sup id=\"cite_ref-War2006_2-22\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup> <a href=\"/wiki/Paroxetine\" title=\"Paroxetine\">Paroxetine</a> and <a href=\"/wiki/Venlafaxine\" title=\"Venlafaxine\">venlafaxine</a> seem to be particularly difficult to discontinue, and <a href=\"/wiki/Post-acute-withdrawal_syndrome\" title=\"Post-acute-withdrawal syndrome\">prolonged withdrawal syndrome</a> (post-acute-withdrawal syndrome, or PAWS) lasting over 18 months has been reported with paroxetine.<sup id=\"cite_ref-DrugSaf2001-Haddad_8-0\" class=\"reference\"><a href=\"#cite_note-DrugSaf2001-Haddad-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-2ndGenReview_10-0\" class=\"reference\"><a href=\"#cite_note-2ndGenReview-10\">&#91;10&#93;</a></sup>\n</p><p>A 2009 Advisory Committee to the FDA found that online anecdotal reports of discontinuation syndrome related to <a href=\"/wiki/Duloxetine\" title=\"Duloxetine\">duloxetine</a> (<i>Cymbalta</i>) included severe symptoms and exceeded prevalence of both paroxetine (<i>Paxil</i>) and venlafaxine (<i>Effexor</i>) reports by over 250% (although acknowledged this may have been influenced by duloxetine (<i>Cymbalta</i>) being a much newer drug).<sup id=\"cite_ref-:0_11-0\" class=\"reference\"><a href=\"#cite_note-:0-11\">&#91;11&#93;</a></sup> It also found that the safety information provided by the manufacturer not only neglected important information about managing discontinuation syndrome, but also explicitly advised against opening capsules, a practice required to gradually taper dosage.<sup id=\"cite_ref-:0_11-1\" class=\"reference\"><a href=\"#cite_note-:0-11\">&#91;11&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Duration\">Duration</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antidepressant_discontinuation_syndrome&amp;action=edit&amp;section=2\" title=\"Edit section: Duration\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Symptoms usually resolve within two weeks but occasionally last up to one year.<sup id=\"cite_ref-Gab2017_3-3\" class=\"reference\"><a href=\"#cite_note-Gab2017-3\">&#91;3&#93;</a></sup>\n</p><p>They typically resolve within a day of restoring the medication.<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Mechanism\">Mechanism</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antidepressant_discontinuation_syndrome&amp;action=edit&amp;section=3\" title=\"Edit section: Mechanism\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The underlying reason for its occurrence is unclear,<sup id=\"cite_ref-War2006_2-23\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup> though the syndrome appears similar to withdrawal from other psychotropic drugs such as <a href=\"/wiki/Benzodiazepine_withdrawal_syndrome\" title=\"Benzodiazepine withdrawal syndrome\">benzodiazepines</a>.<sup id=\"cite_ref-TI2018_1-1\" class=\"reference\"><a href=\"#cite_note-TI2018-1\">&#91;1&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Prevention_and_treatment\">Prevention and treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antidepressant_discontinuation_syndrome&amp;action=edit&amp;section=4\" title=\"Edit section: Prevention and treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In some cases, discontinuation syndrome (withdrawal) may be prevented by taking medication as directed, and when discontinuing, doing so gradually, although symptoms may appear while tapering. When discontinuing an antidepressant with a short <a href=\"/wiki/Biological_half-life\" title=\"Biological half-life\">half-life</a>, switching to a drug with a longer half-life (e.g. <a href=\"/wiki/Fluoxetine\" title=\"Fluoxetine\">fluoxetine</a> (<i>Prozac</i>) or <a href=\"/wiki/Citalopram\" title=\"Citalopram\">citalopram</a>) and then tapering, and eventually discontinuing, from that drug can decrease the severity of symptoms.<sup id=\"cite_ref-Haddad2007_5-1\" class=\"reference\"><a href=\"#cite_note-Haddad2007-5\">&#91;5&#93;</a></sup>\n</p><p>Treatment is dependent on the severity of the discontinuation reaction and whether or not further antidepressant treatment is warranted. In cases where further antidepressant treatment is prescribed, then the only option suggested may be restarting the antidepressant. If antidepressants are no longer required, treatment depends on symptom severity. If symptoms of discontinuation are severe, or do not respond to symptom management, the antidepressant can be reinstated and then withdrawn more cautiously, or by switching to a drug with a longer half life, (such as <i>Prozac</i>), and then tapering and discontinuing that drug.<sup id=\"cite_ref-DrugSaf2001-Haddad_8-1\" class=\"reference\"><a href=\"#cite_note-DrugSaf2001-Haddad-8\">&#91;8&#93;</a></sup> In severe cases, hospitalization may be required.<sup id=\"cite_ref-War2006_2-24\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Pregnancy_and_newborns\">Pregnancy and newborns</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antidepressant_discontinuation_syndrome&amp;action=edit&amp;section=5\" title=\"Edit section: Pregnancy and newborns\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Antidepressants, including SSRIs, can cross the <a href=\"/wiki/Placenta\" title=\"Placenta\">placenta</a> and have the potential to affect the fetus and newborn, including an increased chance of <a href=\"/wiki/Miscarriage\" title=\"Miscarriage\">miscarriage</a>, presenting a dilemma for pregnant women to decide whether to continue to take antidepressants at all, or if they do, considering if tapering and discontinuing during pregnancy could have a protective effect for the newborn.<sup id=\"cite_ref-Byatt_13-0\" class=\"reference\"><a href=\"#cite_note-Byatt-13\">&#91;13&#93;</a></sup>\n</p><p>Postnatal adaptation syndrome (PNAS) (originally called \"neonatal behavioral syndrome\", \"poor neonatal adaptation syndrome\", or \"neonatal withdrawal syndrome\") was first noticed in 1973 in newborns of mothers taking antidepressants; symptoms in the infant include <a href=\"/wiki/Irritability\" title=\"Irritability\">irritability</a>, rapid breathing, <a href=\"/wiki/Hypothermia\" title=\"Hypothermia\">hypothermia</a>, and <a href=\"/wiki/Blood_sugar\" class=\"mw-redirect\" title=\"Blood sugar\">blood sugar</a> problems. The symptoms usually develop from birth to days after delivery and usually resolve within days or weeks of delivery.<sup id=\"cite_ref-Byatt_13-1\" class=\"reference\"><a href=\"#cite_note-Byatt-13\">&#91;13&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Culture_and_history\">Culture and history</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antidepressant_discontinuation_syndrome&amp;action=edit&amp;section=6\" title=\"Edit section: Culture and history\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Antidepressant discontinuation symptoms were first reported with <a href=\"/wiki/Imipramine\" title=\"Imipramine\">imipramine</a>, the first <a href=\"/wiki/Tricyclic_antidepressant\" title=\"Tricyclic antidepressant\">tricyclic antidepressant</a> (TCA), in the late 1950s, and each new class of antidepressants has brought reports of similar conditions, including <a href=\"/wiki/Monoamine_oxidase_inhibitor\" title=\"Monoamine oxidase inhibitor\">monoamine oxidase inhibitors</a> (MAOIs), SSRIs, and SNRIs.  As of 2001, at least 21 different antidepressants, covering all the major classes, were known to cause discontinuation syndromes.<sup id=\"cite_ref-DrugSaf2001-Haddad_8-2\" class=\"reference\"><a href=\"#cite_note-DrugSaf2001-Haddad-8\">&#91;8&#93;</a></sup> The problem has been poorly studied, and most of the literature has been case reports or small <a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">clinical studies</a>; incidence is hard to determine and controversial.<sup id=\"cite_ref-DrugSaf2001-Haddad_8-3\" class=\"reference\"><a href=\"#cite_note-DrugSaf2001-Haddad-8\">&#91;8&#93;</a></sup>\n</p><p>With the explosion of use and interest in SSRIs in the late 1980s and early 1990s, focused especially on <a href=\"/wiki/Prozac#Popular_culture\" class=\"mw-redirect\" title=\"Prozac\">Prozac</a>, interest grew as well in discontinuation syndromes.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup> Some of the symptoms emerged from discussion boards where people with depression discussed their experiences with the disease and their medications; \"brain zaps\" or \"brain shivers\" was one symptom that emerged via these websites.<sup id=\"cite_ref-Christmas_15-0\" class=\"reference\"><a href=\"#cite_note-Christmas-15\">&#91;15&#93;</a></sup><sup id=\"cite_ref-Aronson_16-0\" class=\"reference\"><a href=\"#cite_note-Aronson-16\">&#91;16&#93;</a></sup>\n</p><p>Heightened media attention and continuing public concerns led to the formation of an expert group on the safety of selective serotonin reuptake inhibitors in <a href=\"/wiki/England\" title=\"England\">England</a>, to evaluate all the research available prior to 2004.<sup id=\"cite_ref-CSMExpert_17-0\" class=\"reference\"><a href=\"#cite_note-CSMExpert-17\">&#91;17&#93;</a></sup><sup class=\"reference\" style=\"white-space:nowrap;\">:<span>iv</span></sup>  The group determined that the incidence of discontinuation symptoms are between 5% and 49%, depending on the particular SSRI, the length of time on the medicine and abrupt versus gradual cessation.<sup id=\"cite_ref-CSMExpert_17-1\" class=\"reference\"><a href=\"#cite_note-CSMExpert-17\">&#91;17&#93;</a></sup><sup class=\"reference\" style=\"white-space:nowrap;\">:<span>126\u2013136</span></sup>\n</p><p>With the lack of a definition based on consensus criteria for the syndrome, a panel met in <a href=\"/wiki/Phoenix,_Arizona\" title=\"Phoenix, Arizona\">Phoenix, Arizona</a> in 1997 to form a draft definition,<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup> which other groups continued to refine.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup><sup id=\"cite_ref-who.int_20-0\" class=\"reference\"><a href=\"#cite_note-who.int-20\">&#91;20&#93;</a></sup>\n</p><p>In the late 1990s, some investigators thought that the fact that symptoms emerged when antidepressants were discontinued might mean that antidepressants were causing <a href=\"/wiki/Addiction\" title=\"Addiction\">addiction</a>, and some used the term \"withdrawal syndrome\" to describe the symptoms. While people taking antidepressants do not commonly exhibit drug seeking behavior, stopping antidepressants leads to  similar symptoms as found in <a href=\"/wiki/Drug_withdrawal\" title=\"Drug withdrawal\">drug withdrawal</a> from <a href=\"/wiki/Benzodiazapines\" class=\"mw-redirect\" title=\"Benzodiazapines\">benzodiazapines</a>, and other psychotropic drugs.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup><sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup> As such, some researchers advocate the term withdrawal over discontinuation, to communicate the similar <a href=\"/wiki/Physiological_dependence\" class=\"mw-redirect\" title=\"Physiological dependence\">physiological dependence</a> and negative outcomes.<sup id=\"cite_ref-TI2018_1-2\" class=\"reference\"><a href=\"#cite_note-TI2018-1\">&#91;1&#93;</a></sup> Due to pressure from pharmaceutical companies who make anti-depressants, the term \"withdrawal syndrome\" is no longer used by drug makers, and thus, most doctors, due to concerns that they may be compared to other drugs more commonly associated with withdrawal.<sup id=\"cite_ref-War2006_2-25\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"2013_class_action_lawsuit\">2013 class action lawsuit</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antidepressant_discontinuation_syndrome&amp;action=edit&amp;section=7\" title=\"Edit section: 2013 class action lawsuit\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In 2013, a proposed class action lawsuit, <i>Jennifer L Saavedra v. Eli Lilly and Company</i>,<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup> was brought against <a href=\"/wiki/Eli_Lilly_and_Company\" title=\"Eli Lilly and Company\">Eli Lilly</a> claiming that the <a href=\"/wiki/Cymbalta\" class=\"mw-redirect\" title=\"Cymbalta\">Cymbalta</a> label omitted important information about \"brain zaps\" and other symptoms upon cessation.<sup id=\"cite_ref-Law360_24-0\" class=\"reference\"><a href=\"#cite_note-Law360-24\">&#91;24&#93;</a></sup> Eli Lilly moved for dismissal per the \"<a href=\"/wiki/Learned_intermediary\" title=\"Learned intermediary\">learned intermediary</a> doctrine\" as the doctors prescribing the drug were warned of the potential problems and are an intermediary medical judgment between Lilly and patients; in December 2013 Lilly's motion to dismiss was denied.<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Research\">Research</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antidepressant_discontinuation_syndrome&amp;action=edit&amp;section=8\" title=\"Edit section: Research\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The mechanisms of antidepressant withdrawal syndrome have not yet been conclusively identified.<sup id=\"cite_ref-War2006_2-26\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Renoir2013_6-1\" class=\"reference\"><a href=\"#cite_note-Renoir2013-6\">&#91;6&#93;</a></sup>  The leading hypothesis is that after the antidepressant is discontinued, there is a temporary, but in some cases, long-lasting, deficiency in the brain of one or more essential <a href=\"/wiki/Neurotransmitters\" class=\"mw-redirect\" title=\"Neurotransmitters\">neurotransmitters</a> that regulate mood, such as <a href=\"/wiki/Serotonin\" title=\"Serotonin\">serotonin</a>, <a href=\"/wiki/Dopamine\" title=\"Dopamine\">dopamine</a>, <a href=\"/wiki/Norepinephrine\" title=\"Norepinephrine\">norepinephrine</a>, and <a href=\"/wiki/Gamma-Aminobutyric_acid\" title=\"Gamma-Aminobutyric acid\">gamma-aminobutyric acid</a>, and since neurotransmitters are an interrelated system, dysregulation of one affects the others.<sup id=\"cite_ref-War2006_2-27\" class=\"reference\"><a href=\"#cite_note-War2006-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antidepressant_discontinuation_syndrome&amp;action=edit&amp;section=9\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Benzodiazepine_withdrawal_syndrome\" title=\"Benzodiazepine withdrawal syndrome\">Benzodiazepine withdrawal syndrome</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antidepressant_discontinuation_syndrome&amp;action=edit&amp;section=10\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-TI2018-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-TI2018_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-TI2018_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-TI2018_1-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ti.ubc.ca/2018/07/23/112-antidepressant-withdrawal-syndrome/\">\"&#91;112&#93; Antidepressant Withdrawal Syndrome | Therapeutics Initiative\"</a>. <i>Therapeutics Initiative</i>. 23 July 2018<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 August</span> 2018</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Therapeutics+Initiative&amp;rft.atitle=%5B112%5D+Antidepressant+Withdrawal+Syndrome+%7C+Therapeutics+Initiative&amp;rft.date=2018-07-23&amp;rft_id=https%3A%2F%2Fwww.ti.ubc.ca%2F2018%2F07%2F23%2F112-antidepressant-withdrawal-syndrome%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-War2006-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-War2006_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-War2006_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-War2006_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-War2006_2-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-War2006_2-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-War2006_2-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-War2006_2-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-War2006_2-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-War2006_2-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-War2006_2-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-War2006_2-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-War2006_2-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-War2006_2-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-War2006_2-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-War2006_2-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-War2006_2-15\"><sup><i><b>p</b></i></sup></a> <a href=\"#cite_ref-War2006_2-16\"><sup><i><b>q</b></i></sup></a> <a href=\"#cite_ref-War2006_2-17\"><sup><i><b>r</b></i></sup></a> <a href=\"#cite_ref-War2006_2-18\"><sup><i><b>s</b></i></sup></a> <a href=\"#cite_ref-War2006_2-19\"><sup><i><b>t</b></i></sup></a> <a href=\"#cite_ref-War2006_2-20\"><sup><i><b>u</b></i></sup></a> <a href=\"#cite_ref-War2006_2-21\"><sup><i><b>v</b></i></sup></a> <a href=\"#cite_ref-War2006_2-22\"><sup><i><b>w</b></i></sup></a> <a href=\"#cite_ref-War2006_2-23\"><sup><i><b>x</b></i></sup></a> <a href=\"#cite_ref-War2006_2-24\"><sup><i><b>y</b></i></sup></a> <a href=\"#cite_ref-War2006_2-25\"><sup><i><b>z</b></i></sup></a> <a href=\"#cite_ref-War2006_2-26\"><sup><i><b>aa</b></i></sup></a> <a href=\"#cite_ref-War2006_2-27\"><sup><i><b>ab</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Warner, CH; Bobo, W; Warner, C; Reid, S; Rachal, J (1 August 2006). \"Antidepressant discontinuation syndrome\". <i>American Family Physician</i>. <b>74</b> (3): 449\u201356. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16913164\">16913164</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Family+Physician&amp;rft.atitle=Antidepressant+discontinuation+syndrome&amp;rft.volume=74&amp;rft.issue=3&amp;rft.pages=449-56&amp;rft.date=2006-08-01&amp;rft_id=info%3Apmid%2F16913164&amp;rft.aulast=Warner&amp;rft.aufirst=CH&amp;rft.au=Bobo%2C+W&amp;rft.au=Warner%2C+C&amp;rft.au=Reid%2C+S&amp;rft.au=Rachal%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Gab2017-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Gab2017_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Gab2017_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Gab2017_3-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Gab2017_3-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gabriel, M; Sharma, V (29 May 2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5449237\">\"Antidepressant discontinuation syndrome\"</a>. <i>Canadian Medical Association Journal</i>. <b>189</b> (21): E747. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1503/cmaj.160991\">10.1503/cmaj.160991</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5449237\">5449237</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28554948\">28554948</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Canadian+Medical+Association+Journal&amp;rft.atitle=Antidepressant+discontinuation+syndrome&amp;rft.volume=189&amp;rft.issue=21&amp;rft.pages=E747&amp;rft.date=2017-05-29&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5449237&amp;rft_id=info%3Apmid%2F28554948&amp;rft_id=info%3Adoi%2F10.1503%2Fcmaj.160991&amp;rft.aulast=Gabriel&amp;rft.aufirst=M&amp;rft.au=Sharma%2C+V&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5449237&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Wil2015-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Wil2015_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Wil2015_4-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wilson, E; Lader, M (December 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4722507\">\"A review of the management of antidepressant discontinuation symptoms\"</a>. <i>Therapeutic Advances in Psychopharmacology</i>. <b>5</b> (6): 357\u201368. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/2045125315612334\">10.1177/2045125315612334</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4722507\">4722507</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26834969\">26834969</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Therapeutic+Advances+in+Psychopharmacology&amp;rft.atitle=A+review+of+the+management+of+antidepressant+discontinuation+symptoms&amp;rft.volume=5&amp;rft.issue=6&amp;rft.pages=357-68&amp;rft.date=2015-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4722507&amp;rft_id=info%3Apmid%2F26834969&amp;rft_id=info%3Adoi%2F10.1177%2F2045125315612334&amp;rft.aulast=Wilson&amp;rft.aufirst=E&amp;rft.au=Lader%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4722507&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Haddad2007-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Haddad2007_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Haddad2007_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Haddad, Peter M.; Anderson, Ian M. (October 2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://apt.rcpsych.org/content/13/6/447\">\"Recognising and managing antidepressant discontinuation symptoms\"</a>. <i>Advances in Psychiatric Treatment</i>. <b>13</b> (6): 447\u201357. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1192/apt.bp.105.001966\">10.1192/apt.bp.105.001966</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Advances+in+Psychiatric+Treatment&amp;rft.atitle=Recognising+and+managing+antidepressant+discontinuation+symptoms&amp;rft.volume=13&amp;rft.issue=6&amp;rft.pages=447-57&amp;rft.date=2007-10&amp;rft_id=info%3Adoi%2F10.1192%2Fapt.bp.105.001966&amp;rft.aulast=Haddad&amp;rft.aufirst=Peter+M.&amp;rft.au=Anderson%2C+Ian+M.&amp;rft_id=http%3A%2F%2Fapt.rcpsych.org%2Fcontent%2F13%2F6%2F447&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Renoir2013-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Renoir2013_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Renoir2013_6-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Renoir T (2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3627130\">\"Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved\"</a>. <i>Front Pharmacol</i>. <b>4</b>: 45. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3389/fphar.2013.00045\">10.3389/fphar.2013.00045</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3627130\">3627130</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23596418\">23596418</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Front+Pharmacol&amp;rft.atitle=Selective+serotonin+reuptake+inhibitor+antidepressant+treatment+discontinuation+syndrome%3A+a+review+of+the+clinical+evidence+and+the+possible+mechanisms+involved&amp;rft.volume=4&amp;rft.pages=45&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3627130&amp;rft_id=info%3Apmid%2F23596418&amp;rft_id=info%3Adoi%2F10.3389%2Ffphar.2013.00045&amp;rft.au=Renoir+T&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3627130&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Haddad PM, Dursun SM (2008). \"Neurological complications of psychiatric drugs: clinical features and management\". <i>Hum Psychopharmacol</i>. <b>23</b> (Suppl 1): 15\u201326. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/hup.918\">10.1002/hup.918</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18098217\">18098217</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hum+Psychopharmacol&amp;rft.atitle=Neurological+complications+of+psychiatric+drugs%3A+clinical+features+and+management&amp;rft.volume=23&amp;rft.issue=Suppl+1&amp;rft.pages=15-26&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1002%2Fhup.918&amp;rft_id=info%3Apmid%2F18098217&amp;rft.aulast=Haddad&amp;rft.aufirst=PM&amp;rft.au=Dursun%2C+SM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-DrugSaf2001-Haddad-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-DrugSaf2001-Haddad_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-DrugSaf2001-Haddad_8-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-DrugSaf2001-Haddad_8-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-DrugSaf2001-Haddad_8-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Haddad, Peter M. (March 2001). \"Antidepressant discontinuation syndromes\". <i>Drug Safety</i>. <b>24</b> (3): 183\u201397. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2165/00002018-200124030-00003\">10.2165/00002018-200124030-00003</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11347722\">11347722</a>. <span style=\"font-size:90%; color:#555\">(Subscription required (<span title=\"The site requires a paid subscription to access this page.\" style=\"border-bottom:1px dotted;cursor:help\">help</span>))</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Safety&amp;rft.atitle=Antidepressant+discontinuation+syndromes&amp;rft.volume=24&amp;rft.issue=3&amp;rft.pages=183-97&amp;rft.date=2001-03&amp;rft_id=info%3Adoi%2F10.2165%2F00002018-200124030-00003&amp;rft_id=info%3Apmid%2F11347722&amp;rft.aulast=Haddad&amp;rft.aufirst=Peter+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Tamam, L.; Ozpoyraz, N. (January\u2013February 2002). \"Selective Serotonin Reuptake Inhibitor Discontinuation Syndrome: A Review\". <i>Advances in Therapy</i>. <b>19</b> (1): 17\u201326. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/BF02850015\">10.1007/BF02850015</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12008858\">12008858</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Advances+in+Therapy&amp;rft.atitle=Selective+Serotonin+Reuptake+Inhibitor+Discontinuation+Syndrome%3A+A+Review&amp;rft.volume=19&amp;rft.issue=1&amp;rft.pages=17-26&amp;rft.date=2002-01%2F2002-02&amp;rft_id=info%3Adoi%2F10.1007%2FBF02850015&amp;rft_id=info%3Apmid%2F12008858&amp;rft.aulast=Tamam&amp;rft.aufirst=L.&amp;rft.au=Ozpoyraz%2C+N.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2ndGenReview-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2ndGenReview_10-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation report\">Gartlehner G, Hansen RA, Morgan LC,  et al. (December 2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.ncbi.nlm.nih.gov/books/NBK83447/\">\"Results\"</a>. Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review (Report). Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=report&amp;rft.btitle=Second-Generation+Antidepressants+in+the+Pharmacologic+Treatment+of+Adult+Depression%3A+An+Update+of+the+2007+Comparative+Effectiveness+Review&amp;rft.place=Rockville%2C+MD&amp;rft.series=Comparative+Effectiveness+Reviews&amp;rft.pub=Agency+for+Healthcare+Research+and+Quality&amp;rft.date=2011-12&amp;rft.aulast=Gartlehner&amp;rft.aufirst=Gerald&amp;rft.au=Hansen%2C+Richard+A.&amp;rft.au=Morgan%2C+Laura+C.&amp;rft.au=Thaler%2C+Kylie&amp;rft.au=Lux%2C+Linda+J.&amp;rft.au=Noord%2C+Megan+Van&amp;rft.au=Mager%2C+Ursula&amp;rft.au=Gaynes%2C+Bradley+N.&amp;rft.au=Thieda%2C+Patricia&amp;rft.au=Strobelberger%2C+Michaela&amp;rft.au=Lloyd%2C+Stacey&amp;rft.au=Reichenpfader%2C+Ursula&amp;rft.au=Lohr%2C+Kathleen+N.&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK83447%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:0-11\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:0_11-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:0_11-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM172866.pdf\">\"Cymbalta (Duloxetine) Discontinuation Syndrome: Issues of Scope, Severity, Duration &amp; Management\"</a> <span style=\"font-size:85%;\">(PDF)</span>. U.S. Food and Drug Administration (FDA). 9 June 2009<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 October</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Cymbalta+%28Duloxetine%29+Discontinuation+Syndrome%3A+Issues+of+Scope%2C+Severity%2C+Duration+%26+Management&amp;rft.pub=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.date=2009-06-09&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fdownloads%2FAdvisoryCommittees%2FCommitteesMeetingMaterials%2FDrugs%2FPsychopharmacologicDrugsAdvisoryCommittee%2FUCM172866.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Haddad, Peter M.; Anderson, Ian M. (1 November 2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://apt.rcpsych.org/content/13/6/447\">\"Recognising and managing antidepressant discontinuation symptoms\"</a>. <i>Advances in Psychiatric Treatment</i>. <b>13</b> (6): 447\u2013457. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1192/apt.bp.105.001966\">10.1192/apt.bp.105.001966</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/2056-4678\">2056-4678</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Advances+in+Psychiatric+Treatment&amp;rft.atitle=Recognising+and+managing+antidepressant+discontinuation+symptoms&amp;rft.volume=13&amp;rft.issue=6&amp;rft.pages=447-457&amp;rft.date=2007-11-01&amp;rft_id=info%3Adoi%2F10.1192%2Fapt.bp.105.001966&amp;rft.issn=2056-4678&amp;rft.aulast=Haddad&amp;rft.aufirst=Peter+M.&amp;rft.au=Anderson%2C+Ian+M.&amp;rft_id=http%3A%2F%2Fapt.rcpsych.org%2Fcontent%2F13%2F6%2F447&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Byatt-13\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Byatt_13-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Byatt_13-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Byatt N, Deligiannidis KM, Freeman MP (Feb 2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4006272\">\"Antidepressant use in pregnancy: a critical review focused on risks and controversies\"</a>. <i><a href=\"/wiki/Acta_Psychiatr_Scand\" class=\"mw-redirect\" title=\"Acta Psychiatr Scand\">Acta Psychiatr Scand</a></i>. <b>127</b> (2): 94\u2013114. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/acps.12042\">10.1111/acps.12042</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4006272\">4006272</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23240634\">23240634</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Psychiatr+Scand&amp;rft.atitle=Antidepressant+use+in+pregnancy%3A+a+critical+review+focused+on+risks+and+controversies&amp;rft.volume=127&amp;rft.issue=2&amp;rft.pages=94-114&amp;rft.date=2013-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4006272&amp;rft_id=info%3Apmid%2F23240634&amp;rft_id=info%3Adoi%2F10.1111%2Facps.12042&amp;rft.aulast=Byatt&amp;rft.aufirst=N&amp;rft.au=Deligiannidis%2C+KM&amp;rft.au=Freeman%2C+MP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4006272&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Stutz, Bruce (2007-05-06). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2007/05/06/magazine/06antidepressant-t.html\">\"Self-Nonmedication\"</a>. <i>New York Times</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2010-05-24</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+York+Times&amp;rft.atitle=Self-Nonmedication&amp;rft.date=2007-05-06&amp;rft.aulast=Stutz&amp;rft.aufirst=Bruce&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2007%2F05%2F06%2Fmagazine%2F06antidepressant-t.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Christmas-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Christmas_15-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Christmas, M.B. (2005). <a rel=\"nofollow\" class=\"external text\" href=\"http://pb.rcpsych.org/content/29/6/219\">\"<span style=\"padding-left:0.2em;\">'</span>Brain shivers': from chat room to clinic\"</a>. <i>Psychiatric Bulletin</i>. <b>29</b> (6): 219\u201321. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1192/pb.29.6.219\">10.1192/pb.29.6.219</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychiatric+Bulletin&amp;rft.atitle=%27Brain+shivers%27%3A+from+chat+room+to+clinic&amp;rft.volume=29&amp;rft.issue=6&amp;rft.pages=219-21&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1192%2Fpb.29.6.219&amp;rft.au=Christmas%2C+M.B.&amp;rft_id=http%3A%2F%2Fpb.rcpsych.org%2Fcontent%2F29%2F6%2F219&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Aronson-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Aronson_16-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Aronson, J. (8 October 2005). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1246084\">\"Bottled lightning\"</a>. <i>BMJ</i>. <b>331</b> (7520): 824. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/bmj.331.7520.824\">10.1136/bmj.331.7520.824</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1246084\">1246084</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=Bottled+lightning&amp;rft.volume=331&amp;rft.issue=7520&amp;rft.pages=824&amp;rft.date=2005-10-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1246084&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.331.7520.824&amp;rft.au=Aronson%2C+J.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1246084&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-CSMExpert-17\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-CSMExpert_17-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-CSMExpert_17-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Expert Group on the Safety of Selective Serotonin Reuptake Inhibitors (SSRIs) (December 2004).  Weller, Ian V.D., ed. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf\">\"Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitor Antidepressants\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Medicines and Healthcare Products Regulatory Agency<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 August</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Report+of+the+CSM+Expert+Working+Group+on+the+Safety+of+Selective+Serotonin+Reuptake+Inhibitor+Antidepressants&amp;rft.pub=Medicines+and+Healthcare+Products+Regulatory+Agency&amp;rft.date=2004-12&amp;rft.au=Expert+Group+on+the+Safety+of+Selective+Serotonin+Reuptake+Inhibitors+%28SSRIs%29&amp;rft_id=http%3A%2F%2Fwww.mhra.gov.uk%2Fhome%2Fgroups%2Fpl-p%2Fdocuments%2Fdrugsafetymessage%2Fcon019472.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Schatzberg, A.F.; Haddad, P.; Kaplan, E.M.; Lejoyeux, M.; Rosenbaum, J.F.; Young, A.H.; Zajecka, J. (1997). \"Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel\". <i>J Clin Psychiatry</i>. <b>5u</b> (7): 5\u201310. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9219487\">9219487</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.atitle=Serotonin+reuptake+inhibitor+discontinuation+syndrome%3A+a+hypothetical+definition.+Discontinuation+Consensus+panel&amp;rft.volume=5u&amp;rft.issue=7&amp;rft.pages=5-10&amp;rft.date=1997&amp;rft_id=info%3Apmid%2F9219487&amp;rft.au=Schatzberg%2C+A.F.&amp;rft.au=Haddad%2C+P.&amp;rft.au=Kaplan%2C+E.M.&amp;rft.au=Lejoyeux%2C+M.&amp;rft.au=Rosenbaum%2C+J.F.&amp;rft.au=Young%2C+A.H.&amp;rft.au=Zajecka%2C+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Black, K.; Shea, C.; Dursun, S.; Kutcher, S. (2000). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1407715\">\"Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria\"</a>. <i>J Psychiatry Neurosci</i>. <b>25</b> (3): 255\u201361. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1407715\">1407715</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10863885\">10863885</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Psychiatry+Neurosci&amp;rft.atitle=Selective+serotonin+reuptake+inhibitor+discontinuation+syndrome%3A+proposed+diagnostic+criteria&amp;rft.volume=25&amp;rft.issue=3&amp;rft.pages=255-61&amp;rft.date=2000&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1407715&amp;rft_id=info%3Apmid%2F10863885&amp;rft.au=Black%2C+K.&amp;rft.au=Shea%2C+C.&amp;rft.au=Dursun%2C+S.&amp;rft.au=Kutcher%2C+S.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1407715&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-who.int-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-who.int_20-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation report\">World Health Organization (2003). <a rel=\"nofollow\" class=\"external text\" href=\"http://apps.who.int/medicinedocs/en/d/Js4896e/9.html\">WHO Expert Committee on Drug Dependence&#160;\u2013 Thirty-third Report / WHO Technical Report Series 915</a> (Report). World Health Organization.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=report&amp;rft.btitle=WHO+Expert+Committee+on+Drug+Dependence+%E2%80%93+Thirty-third+Report+%2F+WHO+Technical+Report+Series+915&amp;rft.pub=World+Health+Organization&amp;rft.date=2003&amp;rft.au=World+Health+Organization&amp;rft_id=http%3A%2F%2Fapps.who.int%2Fmedicinedocs%2Fen%2Fd%2FJs4896e%2F9.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Nielsen, M.; Hanse, E.H.; G\u00f8tzsche, P.C. (2012). \"What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors\". <i>Addiction</i>. <b>105</b> (5): 900\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1360-0443.2011.03686.x\">10.1111/j.1360-0443.2011.03686.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21992148\">21992148</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Addiction&amp;rft.atitle=What+is+the+difference+between+dependence+and+withdrawal+reactions%3F+A+comparison+of+benzodiazepines+and+selective+serotonin+re-uptake+inhibitors&amp;rft.volume=105&amp;rft.issue=5&amp;rft.pages=900-8&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1360-0443.2011.03686.x&amp;rft_id=info%3Apmid%2F21992148&amp;rft.au=Nielsen%2C+M.&amp;rft.au=Hanse%2C+E.H.&amp;rft.au=G%C3%B8tzsche%2C+P.C.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fava, G.A.; Gatti, A; Belaise, C.;  et al. (2015). \"Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review\". <i>Psychother Psychosom</i>. <b>84</b> (2): 72\u201381. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1159/000370338\">10.1159/000370338</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25721705\">25721705</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychother+Psychosom&amp;rft.atitle=Withdrawal+Symptoms+after+Selective+Serotonin+Reuptake+Inhibitor+Discontinuation%3A+A+Systematic+Review&amp;rft.volume=84&amp;rft.issue=2&amp;rft.pages=72-81&amp;rft.date=2015&amp;rft_id=info%3Adoi%2F10.1159%2F000370338&amp;rft_id=info%3Apmid%2F25721705&amp;rft.au=Fava%2C+G.A.&amp;rft.au=Gatti%2C+A&amp;rft.au=Belaise%2C+C.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Explicit use of et al. (<a href=\"/wiki/Category:CS1_maint:_Explicit_use_of_et_al.\" title=\"Category:CS1 maint: Explicit use of et al.\">link</a>) </span> </span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\">Justia. <a rel=\"nofollow\" class=\"external text\" href=\"http://dockets.justia.com/docket/california/cacdce/2:2012cv09366/546821\">Jennifer L Saavedra v. Eli Lilly and Company</a></span>\n</li>\n<li id=\"cite_note-Law360-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Law360_24-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Overley, Jeff (January 29, 2013). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.law360.com/articles/411089/lilly-fights-cymbalta-brain-zaps-suit-saying-it-warned-docs\">\"Lilly Fights Cymbalta 'Brain Zaps' Suit, Saying It Warned Docs\"</a>. Law360<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 August</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+Fights+Cymbalta+%27Brain+Zaps%27+Suit%2C+Saying+It+Warned+Docs&amp;rft.pub=Law360&amp;rft.date=2013-01-29&amp;rft.au=Overley%2C+Jeff&amp;rft_id=http%3A%2F%2Fwww.law360.com%2Farticles%2F411089%2Flilly-fights-cymbalta-brain-zaps-suit-saying-it-warned-docs&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><a href=\"/wiki/Rebecca_Tushnet\" title=\"Rebecca Tushnet\">Rebecca Tushnet</a> for Rebecca Tushnet's 43(B)log December 09, 2013 <a rel=\"nofollow\" class=\"external text\" href=\"http://tushnet.blogspot.com/2013/12/learned-intermediary-doctrine-doesnt.html\">Learned intermediary doctrine doesn't bar claim at pleading stage</a></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Damsa, C.; Bumb, A.; Bianchi-Demicheli, F.;  et al. (August 2004). <a rel=\"nofollow\" class=\"external text\" href=\"http://article.psychiatrist.com/?ContentType=START&amp;ID=10001001\">\"<span style=\"padding-left:0.2em;\">\"</span>Dopamine-dependent\" side effects of selective serotonin reuptake inhibitors: a clinical review\"</a>. <i>J Clin Psychiatry</i>. <b>65</b> (8): 1064\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4088/JCP.v65n0806\">10.4088/JCP.v65n0806</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15323590\">15323590</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.atitle=%22Dopamine-dependent%22+side+effects+of+selective+serotonin+reuptake+inhibitors%3A+a+clinical+review&amp;rft.volume=65&amp;rft.issue=8&amp;rft.pages=1064-8&amp;rft.date=2004-08&amp;rft_id=info%3Adoi%2F10.4088%2FJCP.v65n0806&amp;rft_id=info%3Apmid%2F15323590&amp;rft.au=Damsa%2C+C.&amp;rft.au=Bumb%2C+A.&amp;rft.au=Bianchi-Demicheli%2C+F.&amp;rft.au=Vidailhet%2C+Pierre&amp;rft.au=Sterck%2C+Robert&amp;rft.au=Andreoli%2C+Antonio&amp;rft.au=Beyenburg%2C+Stefan&amp;rft_id=http%3A%2F%2Farticle.psychiatrist.com%2F%3FContentType%3DSTART%26ID%3D10001001&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntidepressant+discontinuation+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antidepressant_discontinuation_syndrome&amp;action=edit&amp;section=11\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"infobox\" style=\"width:22em;width:100%; margin:0 0 0.5em 0;\"><tbody><tr><th scope=\"row\">Classification</th><td style=\"text-align:left;\">\n<div style=\"position:relative; float:right; font-size:0.8em;\"><a href=\"https://www.wikidata.org/wiki/Q175918\" class=\"extiw\" title=\"d:Q175918\">D</a></div><div class=\"hlist hlist-separated\" style=\"text-align:left;\"><ul><li><b><a href=\"/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems\" title=\"International Statistical Classification of Diseases and Related Health Problems\">ICD</a>-<a href=\"/wiki/ICD-10\" title=\"ICD-10\">10</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://apps.who.int/classifications/icd10/browse/2016/en#/Y49.0\">Y49.0</a> Tricyclic and tetracyclic antidepressants<br /> <a rel=\"nofollow\" class=\"external text\" href=\"http://apps.who.int/classifications/icd10/browse/2016/en#/Y49.1\">Y49.1</a> Monoamine-oxidase-inhibitor antidepressants<br /> <a rel=\"nofollow\" class=\"external text\" href=\"http://apps.who.int/classifications/icd10/browse/2016/en#/Y49.2\">Y49.2</a> Other and unspecified antidepressants</li></ul></div></td></tr></tbody></table>\n<div role=\"navigation\" aria-label=\"Portals\" class=\"noprint portal plainlist tright\" style=\"margin:0.5em 0 0.5em 1em;border:solid #aaa 1px\">\n<ul style=\"display:table;box-sizing:border-box;padding:0.1em;max-width:175px;background:#f9f9f9;font-size:85%;line-height:110%;font-style:italic;font-weight:bold\">\n<li style=\"display:table-row\"><span style=\"display:table-cell;padding:0.2em;vertical-align:middle;text-align:center\"><a href=\"/wiki/File:American_Lady_Against_The_Sky.jpg\" class=\"image\"><img alt=\"icon\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/72/American_Lady_Against_The_Sky.jpg/32px-American_Lady_Against_The_Sky.jpg\" width=\"32\" height=\"21\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/72/American_Lady_Against_The_Sky.jpg/48px-American_Lady_Against_The_Sky.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/72/American_Lady_Against_The_Sky.jpg/64px-American_Lady_Against_The_Sky.jpg 2x\" data-file-width=\"3008\" data-file-height=\"2000\" /></a></span><span style=\"display:table-cell;padding:0.2em 0.2em 0.2em 0.3em;vertical-align:middle\"><a href=\"/wiki/Portal:Psychiatry\" title=\"Portal:Psychiatry\">Psychiatry portal</a></span></li></ul></div>\n\n<!-- \nNewPP limit report\nParsed by mw2186\nCached time: 20180921220353\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.404 seconds\nReal time usage: 0.468 seconds\nPreprocessor visited node count: 2083/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 63192/2097152 bytes\nTemplate argument size: 2401/2097152 bytes\nHighest expansion depth: 10/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 46001/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.194/10.000 seconds\nLua memory usage: 5.18 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  387.549      1 -total\n 55.09%  213.509      1 Template:Reflist\n 26.01%  100.819     17 Template:Cite_journal\n 22.93%   88.847      2 Template:Infobox\n 18.29%   70.883      1 Template:Infobox_medical_condition_(new)\n 11.04%   42.804      4 Template:Cite_web\n 10.10%   39.156      1 Template:Medical_resources\n  5.89%   22.834      1 Template:Distinguish\n  4.29%   16.631      2 Template:Hlist\n  3.75%   14.543      2 Template:Cite_report\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:2780034-0!canonical and timestamp 20180921220353 and revision id 859285581\n -->\n</div>"},"langlinks":[{"lang":"de","url":"https://de.wikipedia.org/wiki/SSRI-Absetzsyndrom","langname":"German","autonym":"Deutsch","*":"SSRI-Absetzsyndrom"},{"lang":"es","url":"https://es.wikipedia.org/wiki/S%C3%ADndrome_de_discontinuaci%C3%B3n_de_ISRS","langname":"Spanish","autonym":"espa\u00f1ol","*":"S\u00edndrome de discontinuaci\u00f3n de ISRS"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Syndrome_d%27arr%C3%AAt_des_antid%C3%A9presseurs","langname":"French","autonym":"fran\u00e7ais","*":"Syndrome d'arr\u00eat des antid\u00e9presseurs"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Sindrome_da_astinenza_da_antidepressivi","langname":"Italian","autonym":"italiano","*":"Sindrome da astinenza da antidepressivi"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E6%8A%97%E3%81%86%E3%81%A4%E8%96%AC%E4%B8%AD%E6%96%AD%E7%97%87%E5%80%99%E7%BE%A4","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u6297\u3046\u3064\u85ac\u4e2d\u65ad\u75c7\u5019\u7fa4"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Zesp%C3%B3%C5%82_dyskontynuacji_lek%C3%B3w_przeciwdepresyjnych","langname":"Polish","autonym":"polski","*":"Zesp\u00f3\u0142 dyskontynuacji lek\u00f3w przeciwdepresyjnych"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/S%C3%ADndrome_de_priva%C3%A7%C3%A3o_de_antidepressivos","langname":"Portuguese","autonym":"portugu\u00eas","*":"S\u00edndrome de priva\u00e7\u00e3o de antidepressivos"},{"lang":"th","url":"https://th.wikipedia.org/wiki/%E0%B8%81%E0%B8%A5%E0%B8%B8%E0%B9%88%E0%B8%A1%E0%B8%AD%E0%B8%B2%E0%B8%81%E0%B8%B2%E0%B8%A3%E0%B8%AB%E0%B8%A2%E0%B8%B8%E0%B8%94%E0%B8%A2%E0%B8%B2%E0%B9%81%E0%B8%81%E0%B9%89%E0%B8%8B%E0%B8%B6%E0%B8%A1%E0%B9%80%E0%B8%A8%E0%B8%A3%E0%B9%89%E0%B8%B2","langname":"Thai","autonym":"\u0e44\u0e17\u0e22","*":"\u0e01\u0e25\u0e38\u0e48\u0e21\u0e2d\u0e32\u0e01\u0e32\u0e23\u0e2b\u0e22\u0e38\u0e14\u0e22\u0e32\u0e41\u0e01\u0e49\u0e0b\u0e36\u0e21\u0e40\u0e28\u0e23\u0e49\u0e32"}],"categories":[{"sortkey":"","hidden":"","*":"Pages_containing_links_to_subscription-only_content"},{"sortkey":"","hidden":"","*":"CS1_maint:_Explicit_use_of_et_al."},{"sortkey":"","hidden":"","*":"Infobox_medical_condition_(new)"},{"sortkey":"*","*":"Selective_serotonin_reuptake_inhibitors"},{"sortkey":"*","*":"Serotonin-norepinephrine_reuptake_inhibitors"},{"sortkey":"","*":"Antidepressants"},{"sortkey":"","*":"Syndromes"},{"sortkey":"","hidden":"","*":"RTT"}],"links":[{"ns":0,"exists":"","*":"Acta Psychiatr Scand"},{"ns":0,"exists":"","*":"Addiction"},{"ns":0,"exists":"","*":"Antidepressant"},{"ns":0,"exists":"","*":"Antidepressant medication"},{"ns":0,"exists":"","*":"Anxiety"},{"ns":0,"exists":"","*":"Balance (ability)"},{"ns":0,"exists":"","*":"Benzodiazapines"},{"ns":0,"exists":"","*":"Benzodiazepine withdrawal syndrome"},{"ns":0,"exists":"","*":"Biological half-life"},{"ns":0,"exists":"","*":"Blood sugar"},{"ns":0,"exists":"","*":"Citalopram"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Cymbalta"},{"ns":0,"exists":"","*":"Diagnostic method"},{"ns":0,"exists":"","*":"Differential diagnosis"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Dopamine"},{"ns":0,"exists":"","*":"Drug withdrawal"},{"ns":0,"exists":"","*":"Duloxetine"},{"ns":0,"exists":"","*":"Dysphoria"},{"ns":0,"exists":"","*":"Eli Lilly and Company"},{"ns":0,"exists":"","*":"England"},{"ns":0,"exists":"","*":"Fight-or-flight response"},{"ns":0,"exists":"","*":"Flu-like symptoms"},{"ns":0,"exists":"","*":"Fluoxetine"},{"ns":0,"exists":"","*":"Gamma-Aminobutyric acid"},{"ns":0,"exists":"","*":"Half-life"},{"ns":0,"exists":"","*":"Hypothermia"},{"ns":0,"exists":"","*":"ICD-10"},{"ns":0,"exists":"","*":"Imipramine"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"International Statistical Classification of Diseases and Related Health Problems"},{"ns":0,"exists":"","*":"Irritability"},{"ns":0,"exists":"","*":"Learned intermediary"},{"ns":0,"exists":"","*":"Mania"},{"ns":0,"exists":"","*":"Medication discontinuation"},{"ns":0,"exists":"","*":"Miscarriage"},{"ns":0,"exists":"","*":"Monoamine oxidase inhibitor"},{"ns":0,"exists":"","*":"Neurotransmitters"},{"ns":0,"exists":"","*":"Norepinephrine"},{"ns":0,"exists":"","*":"Paroxetine"},{"ns":0,"exists":"","*":"Phoenix, Arizona"},{"ns":0,"exists":"","*":"Physiological dependence"},{"ns":0,"exists":"","*":"Placenta"},{"ns":0,"exists":"","*":"Post-acute-withdrawal syndrome"},{"ns":0,"exists":"","*":"Prozac"},{"ns":0,"exists":"","*":"Psychiatry"},{"ns":0,"exists":"","*":"Psychosis"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Rebecca Tushnet"},{"ns":0,"exists":"","*":"Selective serotonin reuptake inhibitor"},{"ns":0,"exists":"","*":"Serotonin"},{"ns":0,"exists":"","*":"Serotonin syndrome"},{"ns":0,"exists":"","*":"Serotonin\u2013norepinephrine reuptake inhibitor"},{"ns":0,"exists":"","*":"Specialty (medicine)"},{"ns":0,"exists":"","*":"Stroke"},{"ns":0,"exists":"","*":"Tremor"},{"ns":0,"exists":"","*":"Tricyclic antidepressant"},{"ns":0,"exists":"","*":"Tricyclic antidepressants"},{"ns":0,"exists":"","*":"Venlafaxine"},{"ns":0,"exists":"","*":"Vertigo"},{"ns":14,"exists":"","*":"Category:CS1 maint: Explicit use of et al."},{"ns":100,"exists":"","*":"Portal:Psychiatry"}],"templates":[{"ns":10,"exists":"","*":"Template:Distinguish"},{"ns":10,"exists":"","*":"Template:Infobox medical condition (new)"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Rp"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite report"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Medical resources"},{"ns":10,"exists":"","*":"Template:Hlist"},{"ns":10,"exists":"","*":"Template:ICD10"},{"ns":10,"exists":"","*":"Template:Str find"},{"ns":10,"exists":"","*":"Template:Portal"},{"ns":828,"exists":"","*":"Module:Distinguish"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:String2"},{"ns":828,"exists":"","*":"Module:WikidataIB/sandbox"},{"ns":828,"exists":"","*":"Module:Complex date"},{"ns":828,"exists":"","*":"Module:I18n/complex date"},{"ns":828,"exists":"","*":"Module:Ordinal"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Roman"},{"ns":828,"exists":"","*":"Module:ISOdate"},{"ns":828,"exists":"","*":"Module:DateI18n"},{"ns":828,"exists":"","*":"Module:I18n/date"},{"ns":828,"exists":"","*":"Module:Calendar"},{"ns":828,"exists":"","*":"Module:I18n"},{"ns":828,"*":"Module:WikidataIB/i18n"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:Portal"},{"ns":828,"exists":"","*":"Module:Portal/images/p"}],"images":["Lock-green.svg","American_Lady_Against_The_Sky.jpg"],"externallinks":["https://www.ti.ubc.ca/2018/07/23/112-antidepressant-withdrawal-syndrome/","//www.ncbi.nlm.nih.gov/pubmed/16913164","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5449237","//doi.org/10.1503/cmaj.160991","//www.ncbi.nlm.nih.gov/pubmed/28554948","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4722507","//doi.org/10.1177/2045125315612334","//www.ncbi.nlm.nih.gov/pubmed/26834969","http://apt.rcpsych.org/content/13/6/447","//doi.org/10.1192/apt.bp.105.001966","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3627130","//doi.org/10.3389/fphar.2013.00045","//www.ncbi.nlm.nih.gov/pubmed/23596418","//doi.org/10.1002/hup.918","//www.ncbi.nlm.nih.gov/pubmed/18098217","//doi.org/10.2165/00002018-200124030-00003","//www.ncbi.nlm.nih.gov/pubmed/11347722","//doi.org/10.1007/BF02850015","//www.ncbi.nlm.nih.gov/pubmed/12008858","https://www.ncbi.nlm.nih.gov/books/NBK83447/","http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM172866.pdf","//www.worldcat.org/issn/2056-4678","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4006272","//doi.org/10.1111/acps.12042","//www.ncbi.nlm.nih.gov/pubmed/23240634","https://www.nytimes.com/2007/05/06/magazine/06antidepressant-t.html","http://pb.rcpsych.org/content/29/6/219","//doi.org/10.1192/pb.29.6.219","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1246084","//doi.org/10.1136/bmj.331.7520.824","http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf","//www.ncbi.nlm.nih.gov/pubmed/9219487","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1407715","//www.ncbi.nlm.nih.gov/pubmed/10863885","http://apps.who.int/medicinedocs/en/d/Js4896e/9.html","//doi.org/10.1111/j.1360-0443.2011.03686.x","//www.ncbi.nlm.nih.gov/pubmed/21992148","//doi.org/10.1159/000370338","//www.ncbi.nlm.nih.gov/pubmed/25721705","http://dockets.justia.com/docket/california/cacdce/2:2012cv09366/546821","http://www.law360.com/articles/411089/lilly-fights-cymbalta-brain-zaps-suit-saying-it-warned-docs","http://tushnet.blogspot.com/2013/12/learned-intermediary-doctrine-doesnt.html","http://article.psychiatrist.com/?ContentType=START&ID=10001001","//doi.org/10.4088/JCP.v65n0806","//www.ncbi.nlm.nih.gov/pubmed/15323590","http://apps.who.int/classifications/icd10/browse/2016/en#/Y49.0","http://apps.who.int/classifications/icd10/browse/2016/en#/Y49.1","http://apps.who.int/classifications/icd10/browse/2016/en#/Y49.2"],"sections":[{"toclevel":1,"level":"2","line":"Signs and symptoms","number":"1","index":"1","fromtitle":"Antidepressant_discontinuation_syndrome","byteoffset":4048,"anchor":"Signs_and_symptoms"},{"toclevel":2,"level":"3","line":"Duration","number":"1.1","index":"2","fromtitle":"Antidepressant_discontinuation_syndrome","byteoffset":8899,"anchor":"Duration"},{"toclevel":1,"level":"2","line":"Mechanism","number":"2","index":"3","fromtitle":"Antidepressant_discontinuation_syndrome","byteoffset":9420,"anchor":"Mechanism"},{"toclevel":1,"level":"2","line":"Prevention and treatment","number":"3","index":"4","fromtitle":"Antidepressant_discontinuation_syndrome","byteoffset":9670,"anchor":"Prevention_and_treatment"},{"toclevel":2,"level":"3","line":"Pregnancy and newborns","number":"3.1","index":"5","fromtitle":"Antidepressant_discontinuation_syndrome","byteoffset":11174,"anchor":"Pregnancy_and_newborns"},{"toclevel":1,"level":"2","line":"Culture and history","number":"4","index":"6","fromtitle":"Antidepressant_discontinuation_syndrome","byteoffset":12417,"anchor":"Culture_and_history"},{"toclevel":2,"level":"3","line":"2013 class action lawsuit","number":"4.1","index":"7","fromtitle":"Antidepressant_discontinuation_syndrome","byteoffset":17949,"anchor":"2013_class_action_lawsuit"},{"toclevel":1,"level":"2","line":"Research","number":"5","index":"8","fromtitle":"Antidepressant_discontinuation_syndrome","byteoffset":19192,"anchor":"Research"},{"toclevel":1,"level":"2","line":"See also","number":"6","index":"9","fromtitle":"Antidepressant_discontinuation_syndrome","byteoffset":20323,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"7","index":"10","fromtitle":"Antidepressant_discontinuation_syndrome","byteoffset":20380,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"8","index":"11","fromtitle":"Antidepressant_discontinuation_syndrome","byteoffset":20410,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Antidepressant discontinuation syndrome","iwlinks":[{"prefix":"d","url":"https://www.wikidata.org/wiki/Q175918","*":"d:Q175918"}],"properties":[{"name":"wikibase_item","*":"Q175918"}]}}